GenScript Life Science Group is a part of GenScript Biotech Corporation. Founded in 2002 in New Jersey, GenScript Biotech Corporation accelerates innovation in biotech and healthcare by providing researchers and companies with the building blocks needed to develop ground breaking treatments and products. As a cornerstone of the global life science ecosystem, GenScript actively collaborates with a diverse network of partners—from academic institutions to industry leaders—to co-create cutting-edge solutions that redefine service excellence. Guided by its mission to Make People and Nature Healthier Through Biotechnology, and its role as a well-recognized biotechnology company, GenScript has become a trusted global partner with a team of approximately 6,165 employees, supporting over 200,000 customers across 100+ countries and regions, including the world’s Top 20 pharma companies.
解鎖市場時間軸與訊號動態
全新 合作夥伴 活動 — 剛出現 1 個新訊號。
此公司進入各市場的次序 — 由最舊至最新
20 active postings
Biotechnologist (Gene)
註冊以查看完整訊號動態
GenScript 的國際擴張與競爭對手的比較
GenScript你長條顯示所比較各公司之間的相對規模。
欄位5| 公司 | 市場 | 新市場 | 動能 | 活動 | 擴張評分 |
|---|---|---|---|---|---|
 GenScript你 | 7 | 2 | -54% | 57 | 38 |
QA Engineer (Onsite)
查看招聘Singapore, Singapore · 昨日
Biotechnologist (Gene-Trouble Shooting & Order Management)
查看招聘Singapore, Singapore · 前日
Lean Specialist
查看招聘Piscataway, NJ · 5日前
The 𝗧𝘂𝗿𝗯𝗼𝗖𝗛𝗢™ 𝗣𝗿𝗼𝘁𝗲𝗶𝗻 𝗘𝘅𝗽𝗿𝗲𝘀𝘀𝗶𝗼𝗻 𝗞𝗶𝘁 is designed to accelerate antibody and recombinant protein production with strong, consistent performance across formats.Built on next-generation CHO expression technology, TurboCHO™ helps streamline early-stage discovery workflows while maintaining high yield and reliability.Key performance highlights:⏱️ Compared to existing products on the market, the kit achieves 𝗵𝗶𝗴𝗵𝗲𝗿 𝘁𝗶𝘁𝗲𝗿𝘀 𝗶𝗻 𝗷𝘂𝘀𝘁 𝗵𝗮𝗹𝗳 𝘁𝗵𝗲 𝘁𝗶𝗺𝗲, ...
已結束
The 𝗧𝘂𝗿𝗯𝗼𝗖𝗛𝗢™ 𝗣𝗿𝗼𝘁𝗲𝗶𝗻 𝗘𝘅𝗽𝗿𝗲𝘀𝘀𝗶𝗼𝗻 𝗞𝗶𝘁 is designed to accelerate antibody and recombinant protein production with strong, consistent performance across formats.Built on next-generation CHO expression technology, TurboCHO™ helps streamline early-stage discovery workflows while maintaining high yield and reliability.Key performance highlights:⏱️ Compared to existing products on the market, the kit achieves 𝗵𝗶𝗴𝗵𝗲𝗿 𝘁𝗶𝘁𝗲𝗿𝘀 𝗶𝗻 𝗷𝘂𝘀𝘁 𝗵𝗮𝗹𝗳 𝘁𝗵𝗲 𝘁𝗶𝗺𝗲, ...
已結束Olvídate de inconsistencias entre lotes: expresa proteínas de forma automatizada.
已結束金斯瑞生物科技2025年上半年收入增長81.9%至5.188億美元，經調整淨利潤增長509.6%至1.78億美元，得益於全球擴張和各業務領域的創新。
解鎖已驗證電郵與直撥電話
免費 · 無需信用卡
關於 GenScript 業務、市場及增長訊號的快速解答。
